Gapping down
In reaction to disappointing earnings/guidance: FNSR -22%, CPST -3.8%.
Select EU financial related names showing weakness: NBG -2.3%, LYG -1.3%, CS -1.1%, ING -1%, DB -0.8%, HSBC -0.6%, SAN -0.5%.
Other news: ETRM -7.3% (FDA releases update from review of EnteroMedics' VBLOC implantable medical device), AXAS -3.3% (announces an acceleration in 2014 Eagle Ford activity and provide the following guidance update; Co raises production guidance to 5,800-6,000 Boepd, up from 5,500-5,700), COMM -3.3% (upsizes its secondary offering by 2.5 mln shares and prices 17.5 mln shares of common stock at $23.00 per share), QCOR -2% (Mallinckrodt (MNK) shareholders must consider risks of QCOR deal, according to reports), NVO -1.8% (still checking), TTM -1.4% (weak India markets today), DLNG -1.2% (priced public offering of 4.8 mln common units at $22.79 per unit), MT -1.1% (still checking), APAM -0.8% (announced secondary offering of ~1.84 mln shares of common stock by selling shareholders).
Analyst comments: CCG -2.4% (downgraded to Underperform from Neutral at BofA/Merrill), BLL -0.7% (downgraded to Neutral from Buy at BofA/Merrill), MRVL -0.6% (downgraded to Neutral from Positive at Susquehanna).
In reaction to disappointing earnings/guidance: FNSR -22%, CPST -3.8%.
Select EU financial related names showing weakness: NBG -2.3%, LYG -1.3%, CS -1.1%, ING -1%, DB -0.8%, HSBC -0.6%, SAN -0.5%.
Other news: ETRM -7.3% (FDA releases update from review of EnteroMedics' VBLOC implantable medical device), AXAS -3.3% (announces an acceleration in 2014 Eagle Ford activity and provide the following guidance update; Co raises production guidance to 5,800-6,000 Boepd, up from 5,500-5,700), COMM -3.3% (upsizes its secondary offering by 2.5 mln shares and prices 17.5 mln shares of common stock at $23.00 per share), QCOR -2% (Mallinckrodt (MNK) shareholders must consider risks of QCOR deal, according to reports), NVO -1.8% (still checking), TTM -1.4% (weak India markets today), DLNG -1.2% (priced public offering of 4.8 mln common units at $22.79 per unit), MT -1.1% (still checking), APAM -0.8% (announced secondary offering of ~1.84 mln shares of common stock by selling shareholders).
Analyst comments: CCG -2.4% (downgraded to Underperform from Neutral at BofA/Merrill), BLL -0.7% (downgraded to Neutral from Buy at BofA/Merrill), MRVL -0.6% (downgraded to Neutral from Positive at Susquehanna).